|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 8/64 | (2006.01) |
| C07K 16/42 | (2006.01) |
| (11) | Number of the document | 3128997 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15776002.6 |
| Date of filing the European patent application | 2015-04-07 | |
| (97) | Date of publication of the European application | 2017-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation | 2020-10-12 |
| (86) | Number | PCT/US2015/024650 |
| Date | 2015-04-07 |
| (87) | Number | WO 2015/157238 |
| Date | 2015-10-15 |
| (30) | Number | Date | Country code |
| 201461976684 P | 2014-04-08 | US |
| (72) |
ETTINGER, Catherine, US
KARNELL, Jodi, US
DAMSCHRODER, Melissa, US
CHOWDHURY, Partha, US
XIAO, Xiaodong, US
TSUI, Ping, US
VARKEY, Reena, US
DRABIC, Stacey, US
CARTER, Laura, US
HERBST, Ronald, US
DU, Qun, US
NAIMAN, Brian, Michael, US
|
| (73) |
Boston Pharmaceuticals Inc.,
55 Cambridge Parkway, Suite 400, Cambridge MA 02142,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Surišančios molekulės, specifinės IL-21, ir jų panaudojimas |
| BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2024-03-18 | 10 | 231.00 EUR |
| 2025-04-07 |